For personal use only. promoter and STAT3 inhibition reduced CD166 expression suggesting that both CD166 and STAT3 may be functionally coupled and involved in HSC competence. These studies illustrate the significance of CD166 in the identification and engraftment of HSC and in HSC-niche interactions and suggest that CD166 expression can be modulated to enhance HSC function.
INTRODUCTION
How HSC-hematopoietic niche (HN) interactions maintain HSC function remains unknown. Several markers on HSC have a ligand on cells of the HN. However, these markers are neither obligatory for HSC function nor are they universally expressed on HSC across species, or on cells of the HN. A role for OB in maintaining HSC is well documented [1] [2] [3] . We previously showed that more immature OB with high Runx2 expression maintain hematopoietic function 4 . Recently, we found that anti-Activated Leukocyte Cell Adhesion Molecule (ALCAM, or CD166) expression on OB directly correlates with Runx2 expression and high hematopoiesis enhancing activity 5 . CD166 expression decreased with OB maturation concomitant with a decline in Runx2 expression and OB-mediated ex vivo maintenance of HSC 5 .
Expression of CD166 on niche cells has been reported 6 . CD166, which can mediate CD166-CD166 homophilic interactions, is a member of the immunoglobulin superfamily and can also bind the only other known ligand, CD6 7 . CD166 was originally used to identify a subset of human adult bone marrow (BM) and mobilized peripheral blood (PB) CD34+ cells enriched for progenitor activity 8 . However, functional studies with CD166 were not pursued. CD166
expression on Stro-1+ stromal cells 9 and binding of hematopoietic cells via CD166 to a yolk sacderived stromal cell line were also demonstrated 10 . These, and our data 2, 4, 5, 11 confirmed that CD166 is expressed on hematopoietic progenitors and on OB, suggesting the unique possibility that these cells may interact with one another through CD166-CD166 interactions.
Recently, Jeannet et al 12 reported that CD166 is differentially regulated in adult hematopoiesis and that CD166 -/-HSC have an engraftment defect although young CD166
-/-mice displayed normal hematopoietic counts and numbers of phenotypically defined HSC.
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In this report, we demonstrate that CD166 is a universal functional marker of murine and human HSC and OB within the HN and that it is involved in modulating HSC-niche interactions and HSC fate. The conserved homology between murine and human CD166 provides an excellent translational bridge between these systems to advance future interventions for enhancing HSC engraftment and clinical benefit.
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Homing and mobilization.
Homing of transplanted cells to the BM of irradiated recipients was performed as previously described 13 . Briefly, low-density BM cells were stained with CellTrace Violet (CTV) tracking dye (Invitrogen), washed, and injected intra-venously into non-irradiated recipients to avoid radiation-induced injury to the marrow microenvironment.
Recipient mice were sacrificed 16h PT and BM cells recovered and analyzed for CTV+ cells.
Mobilization of hematopoietic stem and progenitor cells (HSPC) was performed as previously described 14 .
Cell staining, flow Cytometry, and cell sorting. Cells washed with stain wash (PBS, 1% BCS, and 1% penicillin-streptomycin) were stained for 15 minutes on ice. Low-density BM Chromatin Immunoprecipitation (ChIP). ChIP was done using IL-7-stimulated TAIL7 cells with immunoprecipitation of protein-bound DNA sequences performed using antibodies for STAT3 (Cell Signaling), RNA polymerase-II (Millipore), or an irrelevant Ab (Jagged2; Santa Cruz). After purification of eluted DNA, ChIP-qPCR was performed using sequence-specific probes for promoter regions of CD166, Survivin, GAPDH or the control ORF-free intergenic region IGX1A (SABiosciences ), in a 7900HT PCR system (Applied Biosystems). Two-photon microscopy. Mice were injected with CFSE labeled cells as described above. Sixteen hours PT, mice were anesthetized and a jugular vein catheter was inserted to allow fluorescent tracer injections on the microscope stage. The dorsal skull surface was exposed, placed in a custom-designed atraumatic stereotaxic device, and submerged in microscope oil. Images were acquired with an Olympus FV1000 confocal system custommodified for multiphoton imaging. Images were collected in a non-descanned mode using Olympus XLUMPLFL 20xW, NA 0.95 objective and 830nm excitation wavelength. Imaging was performed at a scan rate of 4µs/pixel. Sections through the depth of tissue (Z-stacks) were collected from 6 regions of the calvarium. Z-stacks were collected at step-size settings of 1µm (Fig. 1I , FMO controls shown in Suppl Fig. 1B ). Only CD166+CD9+ cells sustained significant in vivo engraftment (Fig. 1J) suggesting that CD166 expression is obligatory for the complete identification of functional HSC. That CD166 marks HSC was also gleaned from co-expression of CD166 and side population (SP) cells 21 ( Fig. 1K ).
The majority of Lin-CD34+CD38-cells in human umbilical cord blood (CB) expressed CD166 ( Fig. 2A) . The repopulating potential of Lin-CD34+CD38-CD166+ cells in NSG mice ( PT was more than 12-fold higher than in KO hosts ( Fig. 3I ) demonstrating that the CD166 -/-HN cannot support LT-HSC engraftment. In addition, BM cells from KO mice also had a compromised radioprotective function (Fig. 3J ).
Homophilic interactions between CD166 expressed on OB and LSK cells was evident from adherence studies in which significantly fewer CD166 -/-clonogenic cells within the LSK fraction adhered to OB when either or both LSK and OB were derived from KO mice (Fig. 3K ).
The negative impact of loss of homophilic CD166 interaction between OB and LSK was evident in the number of clonogenic cells produced in mixed co-cultures (Fig. 3L) (Fig. 4A) . The BM cellularity of surviving KO mice 5, 10, 17, and 24d after 5-FU injection was unchanged from that of WT mice (Fig. 4B ). At these time points, some classes of HSPC 23, 24 , specifically LSK, LT-HSC (LSKCD34-CD135-), and GMP (Lin-Sca1-CD117+CD34+CD16/32w+), were significantly reduced in KO relative to WT mice (Fig. 4C) , while recovery of ST-HSC, MPP, CLP, CMP, and MEP was not different between the two genotypes ( Fig. 4C) . A significantly larger fraction of d0, d5, d10, d17, and d24 KO LSK cells were in G1 and S/G2+M phases of cell cycle ( Fig. 4D and E) demonstrating the cell cycledependent sensitivity of KO HSPC to 5-FU.
We also assessed CD166 expression on LSK cells in response to radiation. BM cells from irradiated mice exhibit a persistent engraftment defect post-irradiation 25, 26 , while those from mice treated with 5-FU engraft successfully 27 . Expression of CD166 on LSK from sublethally irradiated mice was significantly reduced (Fig. 4F) . However, 5-FU treatment did not significantly reduce CD166 expression suggesting that the engraftment defect observed in cells exposed to radiation may be associated with decreased CD166 expression.
Homing of KO cells to the E or C regions of the marrow of KO recipients was inefficient (Fig. 5A ). Using intra-vital imaging, we examined the behavior of BM-homed transplanted cells to assess the impact of CD166 on interactions between transplanted cells and elements of the HN. Figure 5B illustrates that both WT and KO cells home to the marrow of both genotypes.
However, distances between WT cells and the endosteum of WT recipients (Suppl . Fig 7) , were significantly shorter than those measured between KO cells homed to the marrow of KO mice and the endosteum of these recipients (Fig. 5C ). Interestingly, this defect was not as pronounced ( Fig. 5C ) when CD166 was absent on either transplanted cells or the endosteum of Most importantly, differences in the settings WT WT versus KO KO were consistent whether grafts contained low-density BM cells (data not shown), lineage depleted BM cells, or LSK cells (Fig 5C) . A smaller percentage of BM-homed KO cells from the C region were in G0/G1 compared to WT cells (Fig. 5D ) but these differences were not significant, suggesting that 36 . Chromatin immunoprecipitation with Polymerase-II using the leukemia cell line TAIL7 37 , which exhibits STAT3 activation and strong expression of CD166 (Suppl. Fig. 9 ) showed significant enrichment in GAPDH, but not of the control ORF-free intergenic region IGX1A (Fig. 6A) . However, immunoprecipitation with STAT3 antibody showed marked enrichment for the CD166 promoter sequence, as well as for Survivin, a well-known transcriptional target of STAT3. To determine whether STAT3 transcriptional activity regulates CD166 expression on HSC, we examined BM cells from WT and STAT3 -/-mice. Figure 6B illustrates a substantial decrease in the percentage of CD166+ cells within the LSK and LSK48-CD150+ fractions in STAT3 -/-mice relative to controls. Expression of CD166 was significantly reduced on murine BM-derived Lin-cells treated for 24hr with the STAT3-selective inhibitor STATTIC (Fig. 6C) . Finally, suppression of STAT3 expression with shRNA concomitantly reduced CD166 expression on MOLT4 cells (Fig. 6D) interactions that is co-expressed on all these cell types.
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In our transplantation studies, the significant majority of both murine and human longterm repopulating cells were CD166+ demonstrating the importance of CD166 in identifying LT-HSC in both species. The degree to which CD166 facilitated the enrichment of long-term repopulating cells was evident from the frequency of these cells among LSK48-CD166+CD150+ Fig. 8B ) suggesting that these OB are more mature than their WT counterparts. Since we have already demonstrated that immature CD166+ OB are responsible for the hematopoiesis enhancing activity 2, 4, 5, 11 , these data suggest that maturation of OB may be a contributing factor to the inability of the HN of KO mice to support the engraftment of LT-HSC (Fig. 3H ). Our studies also illustrated that HoxB4 and NCadherin expression is moderately, but significantly reduced in OB from KO mice. While the importance of HoxB4 in sustaining HSC function is well documented 38 , the role of N cadherin in hematopoiesis is controversial 32, 39 . Whether the observed differences in the expression levels of HoxB4 and N-cadherin contribute to the inability of the KO microenvironment to support LT-HSC engraftment remains to be determined.
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